Preclinical Imaging Center
- A durable facility for small animals imaging with state of the art equipment and expertise.
- A facility with multi-modal equipment and offices integrated in one centre at one location.
- A centre that operates essentially as a SPF/DMII unit to allow experiments with transgenic animals and with adeno, retro and lenti-viruses.
- A centre with links to clinical/human imaging facilities.
ServicesThe infrastructure and imaging equipment in PRIME has some unique features under one roof in one facility:
- State-of-the-art scanners for: MRI, SPECT, PET, optical imaging, multiphoton microscopy, intrinsic optical imaging and ultrasound.
- Cognition and behavior rooms to measure (social) behavior learning and memory sensory-motor integration activity and motor skills.
- Barrier-free animal handling at safety level II allowing small animal studies with animals that can be infected with various agents (incl. adeno-/retroviruses, bacteria, parasites).
ContractPRIME also supports the pharmaceutical and biotechnology industries in the form of research services outsourced on a contract basis. The experts of PRIME can be involved in project development and consultancy as well as giving explanations on the use of our equipment. For more information you can contact Wilma Janssen.
PRIME and ...
PRIME is a facility that provides support to the pharmaceutical and biotechnology industries in the form of research services outsourced on a contract basis.
Contract Research Organization (CRO)
The Preclinical Imaging Centre (PRIME) is a centralized facility for multimodality imaging of small animals, such as mice and rats. Multi modality imaging is a strategic technology, that can be used to support biopharmaceutical development and preclinical research.
PRIME is staffed by experts from various disciplines such as Radiology, Nuclear Medicine, Cell Biology, Medical Ultrasound Imaging Center, Anatomy and Cognitive Neuroscience. The infrastructure and imaging equipment in PRIME has some unique features under one roof in one facility:
- state-of-the-art scanners for: MRI, SPECT, PET, optical imaging, multiphoton microscopy , intrinsic optical imaging and ultrasound.
- cognition and behavior rooms to measure (social) behavior learning and memory sensory-motor integration activity and motor skills.
- barrier-free animal handling at safety level II allowing small animal studies with animals that can be infected with various agents (incl. adeno-/retroviruses, bacteria, parasites).
Investigators from a wide range of research themes use the imaging facilities of PRIME e.g. Alzheimer, cancer development and immune defense, movement disorders, infectious diseases and host response, inflammatory diseases, urological cancers and women's cancers.
PRIME provides research services for third parties outsourced on a contract basis (i.e contract research organization). The experts in PRIME can be involved in project development, consultancy and rental of equipment. For more information you can contact the coordinator of PRIME, Wilma Janssen.
PRIME is a member of the pan-European Euro BioImaging project which will deploy a distributed biological and biomedical imaging infrastructure in Europa in a coordinated and harmonized manner.
go to Euro BioImaging
PRIME joined the collaborative DTL platform of life science and technology research groups in the Dutch clinical & health, nutrition, crop and livestock breeding and industrial microbiology sectors.
Dutch Techcentre for Life Science (DTL)PRIME joined the collaborative DTL platform of life science and technology research groups in the Dutch clinical & health, nutrition, crop and livestock breeding and industrial microbiology sectors.
PRIME is a member of COMULIS (Correlated Multimodal Imaging in Life Sciences), which is a EU-funded COST Action.
COMULISCOMULIS (Correlated Multimodal Imaging in Life Sciences) is a EU-funded COST Action that aims at fueling urgently needed collaborations in the field of correlated multimodal imaging (CMI), promoting and disseminating its benefits through showcase pipelines, and paving the way for its technological advancement and implementation as a versatile tool in biological and preclinical research.
For more information, please visit the COMULIS website.
Publications in PRIME
1.Lütje S, Franssen GM, Herrmann K, Boerman OC, Rijpkema M, Gotthardt M, Heskamp S. In vitro and in vivo characterization of a 18F-AlF-labeled PSMA ligand for imaging of PSMA-expressing xenografts. J Nucl Med 2019; 60(7):1017-1022.
2.Raavé R, Sandker G, Adumeau P, Borch Jacobsen C, Mangin F, Meyer M, Moreau M, Bernhard C, Da Costa L, Dubois A, Goncalves V, Gustafsson M, Rijpkema M, Boerman O, Chambron J, Heskamp S, Denat F. Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET. Eur J Nucl Med Mol Imaging 2019; 46(9):1966-1977.
3.Lütje S, Heskamp S, Franssen GM, Frielink C, Kip A, Hekman M, Fracasso G, Colombatti M, Herrmann K, Boerman OC, Gotthardt M, Rijpkema M. Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors. Theranostics 2019; 9(10):2924-2938.
4.Elekonawo FMK, Lütje S, Franssen GM, Bos DL, Goldenberg DM, Boerman OC, Rijpkema M. A pretargeted multimodal approach for image-guided resection in a xenograft model of colorectal cancer. EJNMMI Res 2019; 9(1):86.
5.Derks YHW, Löwik DWPM, Sedelaar JPM, Gotthardt M, Boerman OC, Rijpkema M, Lütje S, Heskamp S. PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery. Theranostics 2019; 9(23):6824-6839.
6.Deken MM, Bos DL, Tummers WSFJ, March TL, van de Velde CJH, Rijpkema M, Vahrmeijer AL. Multimodal image-guided surgery of HER2-positive breast cancer using [111In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor model. EJNMMI Res 2019; 9(1):98.
7.Elekonawo FMK, Bos DL, Goldenberg DM, Boerman OC, Rijpkema M. Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models. EJNMMI Res 2019; 9(1):108
8. PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery.
Derks YHW, Löwik DWPM, Sedelaar JPM, Gotthardt M, Boerman OC, Rijpkema M, Lütje S, Heskamp S.
Theranostics. 2019 Sep 20;9(23):6824-6839. doi: 10.7150/thno.36739. eCollection 2019. Review.
9. Imaging of T-cells and their responses during anti-cancer immunotherapy.
Krekorian M, Fruhwirth GO, Srinivas M, Figdor CG, Heskamp S, Witney TH, Aarntzen EHJG.
Theranostics. 2019 Oct 16;9(25):7924-7947. doi: 10.7150/thno.37924.
10 .Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors.
Lütje S, Heskamp S, Franssen GM, Frielink C, Kip A, Hekman M, Fracasso G, Colombatti M, Herrmann K, Boerman OC, Gotthardt M, Rijpkema M.
Theranostics. 2019 May 4;9(10):2924-2938. doi: 10.7150/thno.35274. eCollection 2019.
11. CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models.
Huizing FJ, Garousi J, Lok J, Franssen G, Hoeben BAW, Frejd FY, Boerman OC, Bussink J, Tolmachev V, Heskamp S.
Sci Rep. 2019 Dec 11;9(1):18898. doi: 10.1038/s41598-019-54824-5.
12. Tengeler AC, Dam SA, Wiesmann M, Naaijen J, van Bodegom M, Belzer C, Dederen PJ, Verweij V, Franke B, Kozicz T, Arias Vasquez A, Kiliaan AJ. Gut microbiota from persons with attention-deficit/hyperactivity disorder affects the brain in mice. Microbiome. 2020 Apr 1;8(1):44. doi: 10.1186/s40168-020-00816-x. PubMed
PMID: 32238191; PubMed Central PMCID: PMC7114819.
13. Calahorra J, Shenk J, Wielenga VH, Verweij V, Geenen B, Dederen PJ, Peinado MÁ, Siles E, Wiesmann M, Kiliaan AJ. Hydroxytyrosol, the Major Phenolic Compound of Olive Oil, as an Acute Therapeutic Strategy after Ischemic Stroke. Nutrients. 2019 Oct 11;11(10). pii: E2430. doi: 10.3390/nu11102430. PubMed PMID: 31614692;
PubMed Central PMCID: PMC6836045.
14.Jacobs SAH, Gart E, Vreeken D, Franx BAA, Wekking L, Verweij VGM, Worms N, Schoemaker MH, Gross G, Morrison MC, Kleemann R, Arnoldussen IAC, Kiliaan AJ. Sex-Specific Differences in Fat Storage, Development of Non-Alcoholic Fatty Liver Disease and Brain Structure in Juvenile HFD-Induced Obese Ldlr-/-.Leiden Mice. Nutrients. 2019 Aug 10;11(8). pii: E1861. doi: 10.3390/nu11081861. PubMed PMID:
31405127; PubMed Central PMCID: PMC6723313.
15. van Heukelum S, Mogavero F, van de Wal MAE, Geers FE, França ASC, Buitelaar JK, Beckmann CF, Glennon JC, Havenith MN. Gradient of Parvalbumin- and Somatostatin-Expressing Interneurons Across Cingulate Cortex Is Differentially Linked to Aggression and Sociability in BALB/cJ Mice. Front Psychiatry. 2019 Nov 15;10:809.
16. Jager A, Kanters D, Geers F, Buitelaar JK, Kozicz T, Glennon JC. Methylphenidate Dose-Dependently Affects Aggression and Improves Fear Extinction and Anxiety in BALB/cJ Mice. Front Psychiatry. 2019 Oct 25;10:768.
17. Havenith MN, Zijderveld PM, van Heukelum S, Abghari S, Tiesinga P, Glennon JC. The Virtual-Environment-Foraging Task enables rapid training and single-trial metrics of rule acquisition and reversal in head-fixed mice. Sci Rep. 2019 Mar 18;9(1):4790.
18 . Odenthal J, Friedl P, Takes RP. Compatibility of CO2 laser surgery and fluorescence detection in head and neck cancer cells. Head Neck. 2019 May;41(5):1253-1259.
19. Weigelin B, den Boer AT, Wagena E, Broen K, Dolstra H, de Boer RJ, Figdor CG, Textor J, Friedl P. Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity. Nat Commun. 2021 Sep 1;12(1):5217.
New equipment in PRIME
In targeted photodynamic therapy, molecules named photosensitizers are brought to tissues or cells of interest. These photosensitizers can be activated with light of a specific wavelength, upon which they generate the toxic reactive oxygen species and induce cell death.
At PRIME, a high-power portable fiber coupled diode laser is available (BWF2 B&WTek inc). It emits 690 nm light with an adjustable output power up to 500 mW. Furthermore a collimating lens is available, which makes the system suitable for homogenous illumination of a 5 mm diameter surface. Using this system, NIR-photosensitizers such as the frequently used IRDye700DX can effectively be activated.
Powerful techniques in biomedical researchAll pre-clinical non-invasive imaging technologies available in PRIME are powerful techniques in biomedical research. Combining the strengths of anatomical and functional imaging modalities allows the detection and quantitative determination of morphological, physiological and metabolic processes.
Facility Intrinsic optical and multi-photon imagingThe combination of intrinsic optical imaging and multiphoton microscopy has many applications in neuroscience, because it allows to measure neural activity and structural changes in the nervous system at multiple scales. read more
Detecting and treating tumor cells during prostate cancer surgeryDefense of Yvonne Derks' thesis on 8 September8 September 2022
Liver tumors irradiated from inside can be followed live from outside17 February 2022
LUMO Labs and Oost NL invest in AiosynInvestment accelerates development of artificial intelligence platform to improve diagnostics7 February 2022
DepartmentsPRIME is a partnership between the departments that provide dedicated state-of-the-art equipment and expertise.
- Nuclear Medicine
- Cell Biology
- Cognitive Neuroscience
Radboudumc Technology Center Animal research facility
This technology center offers advice and support from planning up to and including the conduct of animal research on behalf of biomedical research and education.read more